FHI 360 is seeking for a consultancy service for Protocol development and implementation for a randomized controlled trial to evaluate the immune response from two standard purified protein derivative tuberculin solutions to detect latent tuberculosis infection.
Please refer to the attached Request for Proposals [1] for further information.
Complete proposals must be submitted via email to [email protected] [2] no later than November 08, 2021, 5:00pm Hanoi.